• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于神经精神疾病的食欲素拮抗剂:进展与潜在陷阱

Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls.

作者信息

Yeoh Jiann Wei, Campbell Erin J, James Morgan H, Graham Brett A, Dayas Christopher V

机构信息

Neurobiology of Addiction Laboratory, The Centre for Translational Neuroscience and Mental Health Research, School of Biomedical Sciences and Pharmacy, University of Newcastle and the Hunter Medical Research Institute Newcastle, NSW, Australia.

出版信息

Front Neurosci. 2014 Feb 25;8:36. doi: 10.3389/fnins.2014.00036. eCollection 2014.

DOI:10.3389/fnins.2014.00036
PMID:24616658
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3934415/
Abstract

The tight regulation of sleep/wake states is critical for mental and physiological wellbeing. For example, dysregulation of sleep/wake systems predisposes individuals to metabolic disorders such as obesity and psychiatric problems, including depression. Contributing to this understanding, the last decade has seen significant advances in our appreciation of the complex interactions between brain systems that control the transition between sleep and wake states. Pivotal to our increased understanding of this pathway was the description of a group of neurons in the lateral hypothalamus (LH) that express the neuropeptides orexin A and B (hypocretin, Hcrt-1 and Hcrt-2). Orexin neurons were quickly placed at center stage with the demonstration that loss of normal orexin function is associated with the development of narcolepsy-a condition in which sufferers fail to maintain normal levels of daytime wakefulness. Since these initial seminal findings, much progress has been made in our understanding of the physiology and function of the orexin system. For example, the orexin system has been identified as a key modulator of autonomic and neuroendocrine function, arousal, reward and attention. Notably, studies in animals suggest that dysregulation of orexin function is associated with neuropsychiatric states such as addiction and mood disorders including depression and anxiety. This review discusses the progress associated with therapeutic attempts to restore orexin system function and treat neuropsychiatric conditions such as addiction, depression and anxiety. We also highlight potential pitfalls and challenges associated with targeting this system to treat these neuropsychiatric states.

摘要

睡眠/觉醒状态的严格调控对心理和生理健康至关重要。例如,睡眠/觉醒系统失调会使个体易患肥胖等代谢紊乱疾病以及包括抑郁症在内的精神问题。在这一认识过程中,过去十年里我们对控制睡眠与觉醒状态转换的脑系统之间复杂相互作用的理解取得了重大进展。对这一通路认识的加深,关键在于对下丘脑外侧区(LH)中一组表达神经肽食欲素A和B(下丘脑泌素,Hcrt-1和Hcrt-2)的神经元的描述。随着正常食欲素功能丧失与发作性睡病的发生相关联这一发现的证实,食欲素神经元迅速成为研究焦点——发作性睡病患者无法维持正常的日间清醒水平。自这些最初的开创性发现以来,我们对食欲素系统的生理和功能有了更多了解。例如,食欲素系统已被确定为自主神经和神经内分泌功能、觉醒状态、奖赏和注意力的关键调节因子。值得注意的是,动物研究表明,食欲素功能失调与成瘾等神经精神状态以及包括抑郁症和焦虑症在内的情绪障碍有关。本综述讨论了恢复食欲素系统功能及治疗成瘾、抑郁症和焦虑症等神经精神疾病的治疗尝试所取得的进展。我们还强调了针对该系统治疗这些神经精神状态时潜在的陷阱和挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c337/3934415/5e0ef8441315/fnins-08-00036-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c337/3934415/5e0ef8441315/fnins-08-00036-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c337/3934415/5e0ef8441315/fnins-08-00036-g0001.jpg

相似文献

1
Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls.用于神经精神疾病的食欲素拮抗剂:进展与潜在陷阱
Front Neurosci. 2014 Feb 25;8:36. doi: 10.3389/fnins.2014.00036. eCollection 2014.
2
The hypocretin/orexin system in sleep disorders: preclinical insights and clinical progress.睡眠障碍中的下丘脑泌素/食欲素系统:临床前见解与临床进展
Nat Sci Sleep. 2016 Mar 14;8:81-6. doi: 10.2147/NSS.S76711. eCollection 2016.
3
The sleep-wake cycle, the hypocretin/orexin system and narcolepsy: advances from preclinical research to treatment.睡眠-觉醒周期、下丘脑泌素/食欲素系统与发作性睡病:从临床前研究到治疗的进展
CNS Neurol Disord Drug Targets. 2009 Aug;8(4):232-4. doi: 10.2174/187152709788921726.
4
Orexin in sleep, addiction and more: is the perfect insomnia drug at hand?orexin 在睡眠、成瘾等方面的作用:手中是否有完美的失眠药物?
Neuropeptides. 2013 Dec;47(6):477-88. doi: 10.1016/j.npep.2013.10.009. Epub 2013 Oct 23.
5
Plasticity in neurons synthesizing wake/arousal promoting hormone hypocretin/orexin.神经元中合成觉醒/促醒激素食欲素的可塑性。
Vitam Horm. 2012;89:35-59. doi: 10.1016/B978-0-12-394623-2.00003-2.
6
Orexin neuronal circuitry: role in the regulation of sleep and wakefulness.食欲素神经元回路:在睡眠和觉醒调节中的作用。
Front Neuroendocrinol. 2008 Jan;29(1):70-87. doi: 10.1016/j.yfrne.2007.08.001. Epub 2007 Aug 29.
7
Transgenic Archaerhodopsin-3 Expression in Hypocretin/Orexin Neurons Engenders Cellular Dysfunction and Features of Type 2 Narcolepsy.转基因古菌视紫红质在食欲素神经元中的表达导致细胞功能障碍和 2 型发作性睡病的特征。
J Neurosci. 2019 Nov 20;39(47):9435-9452. doi: 10.1523/JNEUROSCI.0311-19.2019. Epub 2019 Oct 18.
8
The physiological role of orexin/hypocretin neurons in the regulation of sleep/wakefulness and neuroendocrine functions.食欲素/下丘脑分泌素神经元在睡眠/觉醒和神经内分泌功能调节中的生理作用。
Front Endocrinol (Lausanne). 2013 Mar 6;4:18. doi: 10.3389/fendo.2013.00018. eCollection 2013.
9
Selective orexin receptor antagonists.选择性食欲素受体拮抗剂。
Bioorg Med Chem Lett. 2013 Sep 1;23(17):4761-9. doi: 10.1016/j.bmcl.2013.06.057. Epub 2013 Jul 4.
10
Recent advances in understanding the roles of hypocretin/orexin in arousal, affect, and motivation.理解下丘脑分泌素/食欲素在觉醒、情感和动机方面作用的最新进展。
F1000Res. 2018 Sep 6;7. doi: 10.12688/f1000research.15097.1. eCollection 2018.

引用本文的文献

1
Gut-Brain Axis and Neuroinflammation: The Role of Gut Permeability and the Kynurenine Pathway in Neurological Disorders.肠脑轴与神经炎症:肠道通透性和犬尿氨酸途径在神经紊乱中的作用。
Cell Mol Neurobiol. 2024 Oct 8;44(1):64. doi: 10.1007/s10571-024-01496-z.
2
Contribution of hypothalamic orexin (hypocretin) circuits to pathologies of motivation.下丘脑食欲素(Hypocretin)回路对动机相关疾病的影响。
Br J Pharmacol. 2024 Nov;181(22):4430-4449. doi: 10.1111/bph.17325. Epub 2024 Sep 24.
3
Finding biomarkers of experience in animals.寻找动物经验的生物标志物。

本文引用的文献

1
Blockade of hypocretin receptor-1 preferentially prevents cocaine seeking: comparison with natural reward seeking.阻断食欲素受体-1可优先预防可卡因觅求行为:与自然奖赏觅求行为的比较。
Neuroreport. 2014 May 7;25(7):485-8. doi: 10.1097/WNR.0000000000000120.
2
The orexin-1 receptor antagonist SB-334867 attenuates anxiety in rats exposed to cat odor but not the elevated plus maze: an investigation of Trial 1 and Trial 2 effects.食欲素-1 受体拮抗剂 SB-334867 可减轻接触猫气味的大鼠的焦虑,但不能减轻高架十字迷宫的焦虑:试验 1 和试验 2 的影响研究。
Horm Behav. 2014 Mar;65(3):294-300. doi: 10.1016/j.yhbeh.2013.12.014. Epub 2014 Jan 4.
3
J Anim Sci Biotechnol. 2024 Feb 20;15(1):28. doi: 10.1186/s40104-023-00989-z.
4
The ability of orexin-A to modify pain-induced cyclooxygenase-2 and brain-derived neurotrophic factor expression is associated with its ability to inhibit capsaicin-induced pulpal nociception in rats.食欲素-A改变疼痛诱导的环氧化酶-2和脑源性神经营养因子表达的能力与其抑制大鼠辣椒素诱导的牙髓伤害感受的能力相关。
Korean J Pain. 2022 Jul 1;35(3):261-270. doi: 10.3344/kjp.2022.35.3.261.
5
Microglia in Alzheimer's Disease: An Unprecedented Opportunity as Prospective Drug Target.阿尔茨海默病中的小胶质细胞:作为潜在药物靶点的前所未有的机遇。
Mol Neurobiol. 2022 May;59(5):2678-2693. doi: 10.1007/s12035-021-02661-x. Epub 2022 Feb 12.
6
Exploring the Role of Orexinergic Neurons in Parkinson's Disease.探索食欲素能神经元在帕金森病中的作用。
Neurotox Res. 2021 Dec;39(6):2141-2153. doi: 10.1007/s12640-021-00411-4. Epub 2021 Sep 8.
7
Efficacy and Safety of Seltorexant as Adjunctive Therapy in Major Depressive Disorder: A Phase 2b, Randomized, Placebo-Controlled, Adaptive Dose-Finding Study.Seltorexant 作为辅助治疗在重度抑郁症中的疗效和安全性:一项 2b 期、随机、安慰剂对照、适应性剂量发现研究。
Int J Neuropsychopharmacol. 2021 Dec 8;24(12):965-976. doi: 10.1093/ijnp/pyab050.
8
Inhibition of Orexin/Hypocretin Neurons Ameliorates Elevated Physical Activity and Energy Expenditure in the A53T Mouse Model of Parkinson's Disease.抑制食欲素/下丘脑分泌素神经元可改善 A53T 帕金森病小鼠模型的过度体力活动和能量消耗。
Int J Mol Sci. 2021 Jan 14;22(2):795. doi: 10.3390/ijms22020795.
9
The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse.食欲素(下丘脑泌素)神经肽系统是治疗可卡因使用障碍合并酒精滥用的新型治疗靶点。
Neuropharmacology. 2021 Feb 1;183:108359. doi: 10.1016/j.neuropharm.2020.108359. Epub 2020 Oct 19.
10
Targeting the Orexin System for Prescription Opioid Use Disorder.针对食欲素系统治疗处方阿片类药物使用障碍。
Brain Sci. 2020 Apr 10;10(4):226. doi: 10.3390/brainsci10040226.
Orexin/hypocretin system modulates amygdala-dependent threat learning through the locus coeruleus.
食欲素/下丘脑分泌素系统通过蓝斑核调节杏仁核依赖的威胁学习。
Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20260-5. doi: 10.1073/pnas.1320325110. Epub 2013 Nov 25.
4
The inhibitory circuit architecture of the lateral hypothalamus orchestrates feeding.外侧下丘脑的抑制性回路结构控制摄食。
Science. 2013 Sep 27;341(6153):1517-21. doi: 10.1126/science.1241812.
5
Orexin receptor-1 in the locus coeruleus plays an important role in cue-dependent fear memory consolidation.蓝斑核内的食欲素受体-1在线索依赖性恐惧记忆巩固中发挥重要作用。
J Neurosci. 2013 Sep 4;33(36):14549-57. doi: 10.1523/JNEUROSCI.1130-13.2013.
6
Orexin Receptor Targets for Anti-Relapse Medication Development in Drug Addiction.用于药物成瘾抗复发药物研发的食欲素受体靶点
Pharmaceuticals (Basel). 2011 Jun 14;4(6):804-821. doi: 10.3390/ph4060804.
7
Orexins (hypocretins) contribute to fear and avoidance in rats exposed to a single episode of footshocks.食欲素(下丘脑泌素)会导致遭受单次电击的大鼠产生恐惧和逃避行为。
Brain Struct Funct. 2014 Nov;219(6):2103-18. doi: 10.1007/s00429-013-0626-3. Epub 2013 Aug 18.
8
The brain reward circuitry in mood disorders.心境障碍的大脑奖励回路。
Nat Rev Neurosci. 2013 Sep;14(9):609-25. doi: 10.1038/nrn3381. Epub 2013 Aug 14.
9
Differential effect of orexin-1 and CRF-1 antagonism on stress circuits: a fMRI study in the rat with the pharmacological stressor Yohimbine.阿立新-1 和 CRF-1 拮抗剂对应激回路的差异作用:一种使用药物应激源育亨宾的大鼠 fMRI 研究。
Neuropsychopharmacology. 2013 Oct;38(11):2120-30. doi: 10.1038/npp.2013.109. Epub 2013 May 8.
10
Central orexin (hypocretin) 2 receptor antagonism reduces ethanol self-administration, but not cue-conditioned ethanol-seeking, in ethanol-preferring rats.中枢食欲素(下丘脑分泌素)2 受体拮抗剂可减少乙醇偏爱大鼠的乙醇自主摄取,但不能减少线索条件性乙醇觅药行为。
Int J Neuropsychopharmacol. 2013 Oct;16(9):2067-79. doi: 10.1017/S1461145713000333. Epub 2013 Apr 22.